Diffusion Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

CervoMed

14/11/2022 22:41

* Diffusion Pharmaceuticals Inc  DFFN.OQ  reported a
quarterly
adjusted loss of $1.37​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of $2.06 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Diffusion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $1.37​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Diffusion Pharmaceuticals Inc shares had fallen by 12.3%
this
quarter and lost 69.2% so far this year.
    * The company reported a quarterly loss of $2.8 million.
    * Wall Street's median 12-month price target for Diffusion
Pharmaceuticals Inc is $24.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:40 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -2.06          -1.37          Beat
 Jun. 30 2022      -2.04          -2.06          Missed
 Mar. 31 2022      -1.75          -2.22          Missed
 Dec. 31 2021      -2.00          -2.00          Met